老年患者的勒卡尼迪平诱导的低血症:一种不那么罕见的并发症
Bashir Mahamud1,2, Katarzyna Mielnik2, Naing Myoaung2
1Medical School, Trakia Medical University, Stara Zagora, BGR.
通道阻塞剂 (CCBs) 可以导致老年患者严重的低血症. 停止使用像勒卡尼迪平 (lercanidipine) 这样的CCB解决了这种情况,这表明需要进行常规监测.
科学领域:
- 老年医学 老年医学
- 临床药理学 临床药理学
- 腎臟病學 (nephrology) 是一種醫學.
背景情况:
- 低血是住院老年患者中最常见的电解质障碍,与增加的发病率和死亡率有关.
- 通道阻断剂 (CCB) 通常不会导致低血症.
- 目前的指导方针不要求电解质监测用于CCB启动.
更多相关视频
08:505/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
Published on: July 3, 2013
06:38Early Detection of Drug-Induced Renal Hemodynamic Dysfunction Using Sonographic Technology in Rats
Published on: March 11, 2016
相关概念视频
Antihypertensive Drugs: Potassium-Sparing Diuretics
Heart Failure Drugs: Diuretics
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Acute Kidney Injury VI: Nursing Management
